Jeffrey S. Ross, MD

Articles by Jeffrey S. Ross, MD

42 Tissue and Liquid Biopsy–Based Comprehensive Genomic Profiling Reveal Mechanisms of Therapy Resistance and Rare Targetable Alterations in Breast Cancer

ByEthan Sokol,Smruthy Sivakumar,Dexter X. Jin,Hanna Tukachinsky,Karthikeyan Murugesan,Dean Pavlick,Jeffrey S. Ross, MD,Garrett M. Frampton,Geoffrey R. Oxnard, MD,Priti S. Hegde

April 18th 2022

DNA Ploidy and Cell Cycle Analysis in Cancer Diagnosis and Prognosis

ByJeffrey S. Ross, MD

June 1st 1996

This review focuses on the clinical utility and potential value of cell cycle analysis and DNA ploidy interpretation in the diagnosis of human tumors, the application of these techniques to cytologic diagnosis, and their capability

Latest Updated Articles

DNA Ploidy and Cell Cycle Analysis in Cancer Diagnosis and Prognosis
Published: June 1st 1996 | Updated:

Jeffrey S. Ross, MD

Articles by Jeffrey S. Ross, MD

42 Tissue and Liquid Biopsy–Based Comprehensive Genomic Profiling Reveal Mechanisms of Therapy Resistance and Rare Targetable Alterations in Breast Cancer

DNA Ploidy and Cell Cycle Analysis in Cancer Diagnosis and Prognosis

Latest Updated Articles

Trending on CancerNetwork

Lirafugratinib Displays Antitumor Activity in Advanced FGFR2-Mutated CCA

Zoldonrasib Earns FDA Breakthrough Therapy Designation in KRAS G12D+ NSCLC

Recurrence Rates Higher With Axillary Lymph Node Biopsy After NAT Chemotherapy

Atezolizumab Combo May Improve Outcomes Vs TACE in Intermediate-Stage HCC

What Were The Key Kidney and Bladder Cancer Advances in 2025?